Endo USA, Inc. recalls

5 recalls in our records from 2025 to 2026: 5 FDA drugs.

Recalls with full detail pages

• FDA · DrugsClass IFeb 12, 2025

  ENDO USA, Inc. drug recall: Adrenalin Chloride Solution

  Labeling: Not Elsewhere Classified: misleading label similar in appearance to the FDA-approved drug product Adrenalin¿ (epinephrine injection, USP)

• FDA · DrugsClass IJan 15, 2025

  Endo USA, Inc. drug recall: Clonazepam Orally Disintegrating Tablet

  Labeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.

Earlier and other recalls

These link to the official agency notice.

• FDA · DrugsClass IIMay 20, 2026

  ENDO USA, Inc. drug recall: Buprenorphine Hydrochloride Official notice ↗

  Crystallization; identified as Buprenorphine free base

• FDA · DrugsClass IIINov 5, 2025

  Endo USA, Inc. drug recall: Everolimus tablets 5mg Official notice ↗

  Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.

• FDA · DrugsClass IIIOct 22, 2025

  Endo USA, Inc. drug recall: Everolimus tablets 5mg Official notice ↗

  Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.

Firm names are matched across agencies by name only. Different companies with similar names may be grouped together; check each official notice.